Omicron: Pfizer-BioNTech COVID-19 vaccine may only partially protect against new variant, study suggests

A new study led by the Africa Health Research Institute reportedly suggests that the omicron COVID-19 variant escapes antibody immunity induced by two doses of the Pfizer-BioNTech vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.